HomeIBT-B • STO
add
Infant Bacterial Therapeutics AB
Previous close
kr 57.80
Day range
kr 57.00 - kr 59.60
Year range
kr 31.20 - kr 84.30
Market cap
768.07M SEK
Avg Volume
10.91K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change | 
|---|---|---|
| Revenue | — | — | 
| Operating expense | 20.13M | -54.55% | 
| Net income | -19.17M | 55.07% | 
| Net profit margin | — | — | 
| Earnings per share | — | — | 
| EBITDA | — | — | 
| Effective tax rate | — | — | 
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change | 
|---|---|---|
| Cash and short-term investments | 176.32M | -35.30% | 
| Total assets | 193.23M | -34.82% | 
| Total liabilities | 58.88M | -1.48% | 
| Total equity | 134.35M | — | 
| Shares outstanding | 13.47M | — | 
| Price to book | 5.80 | — | 
| Return on assets | -25.09% | — | 
| Return on capital | -34.96% | — | 
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change | 
|---|---|---|
| Net income | -19.17M | 55.07% | 
| Cash from operations | -15.91M | 58.11% | 
| Cash from investing | — | — | 
| Cash from financing | — | — | 
| Net change in cash | -15.44M | 58.39% | 
| Free cash flow | -8.85M | 63.32% | 
About
Founded
2011
Website
Employees
8
